ARAC The overarching mission of the WU-DDRCC is to promote collaborative, multidisciplinary research focused on interactions between host and environment in digestive disease. The goals of the Administrative and Resource Access Core (ARAC) are to coordinate, manage and integrate all activities of the WU-DDRCC, thereby maximizing value to our membership from all Cores and Enrichment Programs. These goals will be accomplished by: (1) Aligning Core services and technologies to reflect thematic interests of our Research Base; (2) Promoting multidisciplinary, collaborative research in digestive disease through an Enrichment Program of regular seminars, visiting speakers, journal clubs, symposia and mini-sabbaticals; (3) Nurturing junior faculty career development via Pilot and Feasibility (P/F) Awards that facilitate scientific independence: (4) Catalyzing collaborative and synergistic interaction among other NIDDK funded Centers locally (DRC, NORC) and other DDRCCs throughout the region (Midwest Alliance). The ARAC pursues these goals by providing stable, responsive stewardship of scientific Cores, global financial oversight and strategic allocation of supplemental awards to leverage institutional Cores. These goals are guided by both Internal (IAB), and External Advisory Boards (EAB). KEY ACCOMPLISHMENTS since 2013 include: (1) Alignment of membership reflecting evolving interests and departures balanced with new recruitment (50 Full members 12/2018 vs 49 Full members 12/2013), with 50% of the current membership new since 2013, (2) Support of membership realized through 30% net growth in Annual Direct Costs (ADC) ($23.8M 12/2013 vs $30.9M 12/2018). (3) Evolution of Core services in response to new institutional investment, most notably a new Precision Animal Models and Organoids Core (PAMOC), (4) Investing in P/F Awardees, resulting in a 26:1 return on investment since 2013 and launching academic careers in research (95% still active in digestive disease research among awardees from 1999 to present), (5) Sponsoring an Enrichment Program featuring ~12 external speakers/year (including at least one designated underrepresented minority/year), a formal mentorship program THE SPECIFIC AIMS FOR THE ARAC ARE: (1) Provide leadership, governance and administrative infrastructure for members, including strategic alignment of Core services with current and future needs of the Research Base. (2) Manage and oversee Core services to assure timely, high quality, specialized expertise, guided by an Internal Executive Committee (IEC) and an Internal Advisory Board (IAB). (3) Review Research Base membership and align thematic interests, guided by IEC and Thematic Program Leaders. (4) Promote scientific independence for junior faculty through a P/F Program guided by an External Advisory Board (EAB) who review and select Awardees. (5) Promote collaboration, awareness of new scientific initiatives, career development and diversity through a dynamic Enrichment Program. (6) Assure continued administrative and scientific dialog with other DDRCCs particularly those in the Midwest Alliance as well as the NIDDK DDRCC program website.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK052574-22
Application #
10129351
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
22
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Jiang, Hongmei; Xu, Mai; Li, Lin et al. (2018) Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Mol Cancer Ther 17:2144-2155
Wang, Songyan; Oestricker, Lauren Z; Wallendorf, Michael J et al. (2018) Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance. PLoS One 13:e0192441
McKee, Ryan S; Tarr, Phillip I; Dietzen, Dennis J et al. (2018) Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea. J Pediatric Infect Dis Soc 7:e116-e122
Chondronikola, Maria; Magkos, Faidon; Yoshino, Jun et al. (2018) Effect of Progressive Weight Loss on Lactate Metabolism: A Randomized Controlled Trial. Obesity (Silver Spring) 26:683-688
Luo, Jialie; Qian, Aihua; Oetjen, Landon K et al. (2018) TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle Cells. Immunity 49:107-119.e4
Nywening, Timothy M; Belt, Brian A; Cullinan, Darren R et al. (2018) Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. Gut 67:1112-1123
Liss, Kim H H; McCommis, Kyle S; Chambers, Kari T et al. (2018) The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury. Liver Transpl 24:908-921
Anderson, Neil W; Tarr, Phillip I (2018) Multiplex Nucleic Acid Amplification Testing to Diagnose Gut Infections: Challenges, Opportunities, and Result Interpretation. Gastroenterol Clin North Am 47:793-812
Yoshino, Jun; Almeda-Valdes, Paloma; Moseley, Anna C et al. (2018) Percutaneous muscle biopsy-induced tissue injury causes local endoplasmic reticulum stress. Physiol Rep 6:e13679
Stoka, Kellie V; Maedeker, Justine A; Bennett, Lisa et al. (2018) Effects of Increased Arterial Stiffness on Atherosclerotic Plaque Amounts. J Biomech Eng 140:

Showing the most recent 10 out of 899 publications